Scotts Miracle-Gro director David Evans sells $176,345 in shares

Scotts Miracle-Gro's director, David Evans, sold 2,655 of the company's shares on November 9, 2026, for a total of $176,345. This transaction occurred at a price of $66.42 per share, which is higher than the current trading price of $63.84. According to InvestingPro analysis, Scotts Miracle-Gro appears undervalued, making it a potential opportunity on the most undervalued stocks list.

Post-transaction, Mr. Evans now holds 25,405 common shares of the company. The business has consistently paid dividends for 22 consecutive years, currently offering a yield of 4.14%. For those interested in a more in-depth analysis of Scotts Miracle-Gro's valuation and financial status, the Pro Research Report is available, covering this and 1,400+ other US equities.

In related news, Scotts Miracle-Gro released its fiscal fourth-quarter results. While the adjusted loss per share was smaller than expected at $2.16 compared to the forecasted $2.21, revenue fell slightly short of expectations at $302.9 million against the forecasted $306.1 million. Despite these modest results, the company's management remains optimistic for fiscal 2027, projecting a growth in net sales between 2% and 4% and adjusted earnings per share growth of approximately 5% to 9%.

Further buoying investor confidence, Wells Fargo raised its price target for Scotts Miracle-Gro from $71 to $76, maintaining an Overweight rating. This decision was driven by the firm's analyst, Michael Ruch, who lauded the company's growth outlook as a significant factor. These recent developments portray a generally positive outlook among analysts for the company's future performance.